Enhanced natural killer cell activity by proglumetacin, a non-steroidal anti-inflammatory drug.
In this paper we show the stimulatory effect of a new indolyl derivative drug, proglumetacin, alone and in combination with some cytokines, on natural killer cell activity.
Conti
P
P
Department of Immunology, University of Chieti, Italy.
Reale
M
M
Fiore
S
S
Barbacane
R C
RC
Bongrazio
M
M
Panara
M R
MR
Carratelli
L
L
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000494:pharmacology*; D001685:Biological Factors / Q000008:administration & dosage / Q000494:pharmacology; D016207:Cytokines; D004357:Drug Synergism; D006801:Humans; D007210:Indoleacetic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000187:drug effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001685:Biological Factors; D016207:Cytokines; D007210:Indoleacetic Acids; C019541:proglumetacin; D007213:Indomethacin